CAS No |
Product Name |
Molecular Formula |
354574-59-7
|
4-Bromoquinazoline
|
C8H5BrN2
|
354589-68-7
|
4-Chloro-2-(1-methylethyl)-1H-indene
|
C12H13Cl
|
354812-17-2
|
4-Amino-[2,3']bithiophenyl-5-carboxamide
|
C9H8N2OS2
|
354812-41-2
|
1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
|
C21H24FN3O4
|
354813-19-7
|
Balicatib
|
C23H33N5O2
|
354814-19-0
|
5-Amino-2-(trifluoromethyl)benzonitrile
|
C8H5F3N2
|
354824-17-2
|
6-(Dimethylamino)-3-pyridinemethanamine
|
C8H13N3
|
354824-19-4
|
2-Methoxy-3-pyridinemethanamine
|
C7H10N2O
|
355004-67-0
|
4-Methoxy-3-pyridineboronic acid
|
C6H8BNO3
|
355025-13-7
|
3-[[[4-[4-[[[1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]-propanoic acid methyl ester
|
C24H25ClN2O5S
|
355025-24-0
|
Ki 16425
|
C23H23ClN2O5S
|
355120-40-0
|
2,2'-[Carbonothioylbis(thio)]bis[2-methylpropanoic acid]
|
C9H14O4S3
|
355129-15-6
|
Eprotirome
|
C18H17Br2NO5
|
355134-13-3
|
3-Bromo-5-nitrobenzaldehyde
|
C7H4BrNO3
|
355143-38-3
|
6'-O-p-Hydroxybenzoylcatalposide
|
C29H30O14
|
355386-94-6
|
5-Quinolineboronic acid
|
C9H8BNO2
|
355423-16-4
|
4-Bromo-2-fluoro-5-nitrobenzoic acid
|
C7H3BrFNO4
|
355806-00-7
|
tert-Butyl rosuvastatin
|
C26H36FN3O6S
|
355829-23-1
|
2-Chloro-5-fluoro-N,N-dimethyl-4-pyrimidinamine
|
C6H7ClFN3
|
355832-04-1
|
N-(9,9-Dimethylfluoren-2-yl)aniline
|
C21H19N
|
355836-08-7
|
2-Methoxy-4,6-dimethylbenzeneboronic acid
|
C9H13BO3
|
355836-10-1
|
2-Methoxy-4-trifluoromethoxyphenylboronic acid
|
C8H8BF3O4
|
355861-11-9
|
L-Phenylalanyl-L-isoleucyl-L-alanyl-L-seryl-L-asparaginylglycyl-L-valyl-L-lysyl-L-leucyl-L-valine
|
C49H82N12O13
|
356057-34-6
|
Darapladib
|
C36H38F4N4O2S
|
356060-80-5
|
Methyl 6-O-[tris(1-methylethyl)silyl]-alpha-D-glucopyranoside tribenzoate
|
C37H46O9Si
|
356060-82-7
|
Methyl 6-O-[tris(1-methylethyl)silyl]-alpha-D-galactopyranoside tribenzoate
|
C37H46O9Si
|
356062-62-9
|
2-[3-(3-Butyl-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene)-1-propen-1-yl]-1,1,3-trimethyl-1H-benz[e]indolium hexafluorophosphate(1-) (1:1)
|
C36H39N2.F6P
|
356068-86-5
|
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide
|
C14H23N3O2
|
356068-93-4
|
5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
|
C16H13FN2O3
|
356068-94-5
|
Toceranib
|
C22H25FN4O2
|
356068-97-8
|
N-Desethyl-sunitinib
|
C20H23FN4O2
|
356068-99-0
|
N-[2-(Diethyloxidoamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
|
C22H27FN4O3
|
356517-93-6
|
4-[4-[[6-O-(1-Oxo-3-phenyl-2-propenyl)-2-O-(3,4,5-trihydroxybenzoyl)-beta-D-glucopyranosyl]oxy]phenyl]-2-butanone
|
C32H32O12
|
356534-04-8
|
(4-Fluoro-2-methylphenyl)hydrazine
|
C7H9FN2
|
356559-20-1
|
SB 525334
|
C21H21N5
|
356560-80-0
|
6-Bromo-[1,2,4]triazolo[1,5-a]pyridine
|
C6H4BrN3
|
356560-84-4
|
1-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-2-(6-methylpyridin-2-yl)ethane-1,2-dione
|
C14H10N4O2
|
356561-08-5
|
5-Iodo-4-methyl-2-pyridinamine
|
C6H7IN2
|
356570-52-0
|
4-Methylbenzylboronic acid pinacol ester
|
C14H21BO2
|
356572-08-2
|
1-Hydroxy-3-amino-5,7-dimethyladamantane hydrochloride
|
C12H21NO.HCl
|
356782-84-8
|
3,4-Dihydro-3-oxo-4-beta-D-ribofuranosyl-2-pyrazinecarboxamide
|
C10H13N3O6
|
356783-16-9
|
3,6-Dichloro-2-pyrazinecarbonitrile
|
C5HCl2N3
|
356783-28-3
|
3,6-Difluoro-2-pyrazinecarbonitrile
|
C5HF2N3
|
356783-31-8
|
6-Fluoro-3-oxo-3,4-dihydro-2-pyrazinecarbonitrile
|
C5H2FN3O
|
356786-94-2
|
Pantothenic acid-13C4,15N hemicalcium salt
|
13C6C12H32Ca15N2O10
|
357154-27-9
|
Ertapenem Ring Open Impurity
|
C22H27N3O8S
|
357166-29-1
|
Pemetrexed disodium hepthydrate
|
C20H19N5Na2O6.7(H2O)
|
357166-30-4
|
Pemetrexed disodium hydrate
|
2(C20H19N5Na2O6).5(H2O)
|
357172-63-5
|
Morpholine [(5-methyl-1H-1,2,4-triazol-3-yl)thio]acetate
|
C5H7N3O2S.C4H9NO
|
357189-94-7
|
Posaconazole 3-OXO impurity
|
C37H40F2N8O5
|